Today on Outsourcing-Pharma.com   Pfizer, Nektar agreement not so sweet after all? BioCryst clinical trials debacle highlights protocol perils Evotec's metamorphosis erodes profit AstraZeneca in 'serious trouble', say analysts eClinical news in Brief

Related Industry News   Ventana reluctantly opens up to Roche in a bid to boost offer Practice run for pharma RFID New drug safety model unveiled as Merck shells out for Vioxx $60m expansion for mystery pharma

Breaking News on Outsourcing Pharma
Daily  Wednesday 14 November 2007		Forward to a colleague

	Technical / White Paper Benefits of integrating human tissue research in drug discovery The benefits of integrating human tissue research into drug discovery and development programs are in the confidence that they provide in the selection of the NCEs most likely to succeed in the clinic, and doing this in the most financially efficient way... Click Here Access Full Stories Pfizer, Nektar agreement not so sweet after all? Pfizer yesterday announced a multi-million dollar pay-off to ex-partner Nektar Therapeutics, but the details of the deal reveal not only Nektar's concerns for its future, but also that Pfizer is still keeping its... Read BioCryst clinical trials debacle highlights protocol perils BioCryst's recent clinical trials debacle highlights the importance of the robust and realistic design of, and careful adherence to, a drug trial protocol... Read Evotec's metamorphosis erodes profit Evotec's bid to distance itself from being a services business and eventually morph into a fully fledged pharma company has been felt on the company's balance sheet during the third quarter... Read AstraZeneca in 'serious trouble', say analysts An analyst report released yesterday identified AstraZeneca as being in 'serious trouble' and branded it as potentially the 'worst [large cap] performer in [the] entire sector' over the next eight years... Read eClinical news in Brief Outsourcing-Pharma tracks the latest eClinical movements, featuring Phase Forward, Nextrials, Octagon and Omnicare... Read
	All News Headlines for: November | October | September
	Product Brochure Baxter's contract services case study Baxter's contract services case study details the expedited transfer of a commercial launched lyophilized drug to a new production site. Their team designed solutions resulting in cost savings, yield improvement and cycle optimization... Click Here
	Related Industry News Ventana reluctantly opens up to Roche in a bid to boost offer In the latest twist in Roche's fight to acquire diagnostics expert Ventana, the companies have signed a confidentiality agreement that will enable the pharma giant access to Ventana's books... Read Practice run for pharma RFID IBM has teamed up with RFID specialist Tagsys to offer pharmaceutical manufacturers a chance to have a practice run implementing their RFID track and trace technology ahead of new legal requirements coming into... Read New drug safety model unveiled as Merck shells out for Vioxx A new 3D model of the human liver that even has its own blood supply could pump new life into drug safety tests by predicting problems earlier and cut down on animal experiments... Read $60m expansion for mystery pharma Swedish construction firm Skanska today announced that it has been awarded a multi-million dollar contract to expand a pharmaceutical facility in the US, though the company is keeping the identity of its client... Read Weekly Comment Big pharma lends a helping hand Despite often attracting a barrage of negative publicity, particularly in regard to a perception of putting profits before people, big pharma firms are still capable of showing their human side in times of crisis. Read Previous Headlines NPIL to trim ex-Pfizer site NPIL Pharma last week told workers at its former Pfizer plant in Morpeth, UK that the company is considering hiving off jobs in a bid to maintain the site's viability... Read PharmEng opens new Canada plant Canadian contract manufacturer PharmEng recently announced that its new specialised manufacturing facility in Nova Scotia is open for business... Read China gets serious on drug GMP; safety pact with FDA imminent As of next year Chinese pharmaceutical manufacturers will face a tougher time gaining good manufacturing practice (GMP) certification after the country's regulator signalled new and stricter standards were on the... Read Synexus agrees to private sale Management of publicly-traded Synexus have agreed to the £18.1m (€25.7m) sale of the company to a private equity firm that has promised to fund its global expansion ventures... Read Tripos lands Schering-Plough deal Tripos Discovery Research (TDR) has risen from the ashes surrounding the liquidation of its previous owners Tripos, Inc. to land a 'library enrichment' deal with Schering-Plough... Read Technical / White Papers, Case studies, Web casts Benefits of integrating human tissue research in drug discovery - Technical / White Paper Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analytical testing, QC Bulk ingredients Contract sales & marketing Data management Drug delivery, formulation Fill & finish, packaging Phase I-II Phase III-IV Preclinical Product & Supplier News - Contract Manufacturing Regulatory affairs Supply chain, logistics Validation services

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com